# Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.

> **NCT03640650** · PHASE4 · TERMINATED · sponsor: **PeriPharm** · enrollment: 80 (actual)

## Conditions studied

- Cataract Surgery

## Interventions

- **COMBINATION_PRODUCT:** Dropless Therapy
- **DRUG:** Usual Care

## Key facts

- **NCT ID:** NCT03640650
- **Lead sponsor:** PeriPharm
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-15
- **Primary completion:** 2021-03-16
- **Final completion:** 2021-03-16
- **Target enrollment:** 80 (ACTUAL)
- **Why stopped:** COVID-19 pandemic leading to uncertainty in the recruitement
- **Last updated:** 2021-09-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03640650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03640650, "Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03640650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*